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KAJIAN MODERATOR, KOLIMATOR DAN PERISAIAN UNTUK 
PENYELIDIKAN BNCT DI AGENSI NUKLEAR MALAYSIA 
 
ABSTRAK 
 
 Objektif penyelidikan ini adalah untuk mengkaji pengoptimunan susun atur 
bagi kemudahan Boron Neutron Capture Therapy (BNCT) pada garisan alur neutron 
yang melalui kolum termal pada Reaktor TRIGA MARK II Malaysia. Belum ada 
penyelidikan sebegini dilakukan di kolum termal tersebut dan ciri setiap reaktor 
TRIGA adalah berbeza. Ciri alur neutron yang diperlukan adalah neutron yang 
bertenaga terma dengan fluk sebanyak 109 cm-2s-1 dan alurnya berdiameter 15 cm. 
Kolimator, moderator dan komponen perisaian bersama teras reaktor dan kolum termal 
disimulasi menggunakan Monte Carlo N-Particle Transport Code. Fluk neutron dan 
foton dikira bersama dengan tenaga masing-masing menggunakan perisian yang sama. 
Selepas itu kolimator dan perisai telah dibina. Polyethylene dan air telah digunakan 
sebagai perisai neutron laju dan neutron epiterma. Plumbum pula digunakan sebagai 
perisai sinar gama. Kolimator diperbuat dari paip polyethylene berdiameter 8 cm dan 
disikan dengan lilin. Pengukuran neutron dan sinar gama di dalam Graphite Stringer 
tengah (G7) pada kolum termal telah dilakukan menggunakan pengesan TLD. Pada 
kuasa reaktor 1 MW, kadar dos sinar gama adalah 30.67 Svjam-1 dan fluk neutron 
adalah 1.69 × 1010 cm-2s-1. Pengukuran fluk neutron dan sinar gama di dalam kotak 
perisai telah dilakukan menggunakan pengesan TLD juga. Kadar dos sinar gama 
adalah 1.41 Svjam-1. Fluk neutron adalah 3.00 × 107 cm-2s-1 iaitu lebih rendah dari fluk 
neutron yang diperlukan. Untuk mengkaji penembusan neutron ke dalam tubuh 
xxi 
 
manusia, ujikaji menggunakan fantom air telah dijalankan. Fluk neutron pada 0.0 cm 
adalah 5.00 × 106 cm-2s-1 dan 3.00 × 107 cm-2s-1 pada kedalaman 0.8 cm kemudian 
berkurang kepada 1.00 × 106 cm-2s-1 pada kedalaman 8.1 cm. Pengukuran spektrum 
neutron telah dilakukan menggunakan spektrometer MICROSPEC-2. Spektrum yang 
diperoleh adalah menepati jangkaan. Hitungan spektrum tertinggi adalah pada neutron 
bertenaga terma dan spektrum berkurang bila tenaga neutron bertambah. Pengukuran 
diteruskan dengan meletakkan plat kadmium, plat B4C, plat plumbum, air didalam 
bekas aluminium dan ais didalam bekas aluminium di hadapan MICROSPEC-2. Ais 
telah menghasilkan 0.05 bilangan per saat neutron terma. Air pula menghasilkan 0.04 
bilangan per saat. Kesimpulan yang boleh dibuat daripada kajian ini adalah kolum 
termal pada reaktor TRIGA MARK II Malaysia sesuai untuk digunakan dalam rawatan 
kanser berdasarkan kaedah BNCT.  
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MODERATOR, COLLIMATOR AND SHIELDING STUDIES FOR BNCT 
RESEARCH AT MALAYSIAN NUCLEAR AGENCY 
 
ABSTRACT 
 
 The objective of this research is to optimally study an arrangement for BNCT 
facility at a beam line through the thermal column of Malaysian TRIGA MARK II 
Reactor. There is no similar research had been done at this thermal column and all 
TRIGA reactors have different characteristics. The characteristics of the neutron beam 
needed are thermal neutron with a flux of 109 cm-2s-1 and the diameter of the beam is 
15 cm. Collimator, moderator and shielding components with reactor core and thermal 
column were simulated with Monte Carlo N-Particle Transport Code. Fluxes of 
neutron and photon were calculated together with their energies with the same 
software. After that, collimator and shielding are fabricated. For fast and epithermal 
neutron shielding, a polyethylene and water were used. For gamma-ray shielding, lead 
was used. The collimator is made from polyethylene pipe with 8 cm of diameter filled 
with paraffin. Neutron and gamma-ray measurement in a Central Graphite Stringer 
(G7) of thermal column was done with TLD detectors. At 1 MW of reactor power, 
gamma-ray dose rate was 30.67 Svhr-1 and neutron flux was 1.69 × 1010 cm-2s-1. 
Neutron and gamma-ray fluxes in shielding box were measured with TLD also. 
Gamma-ray dose rate was 1.41 Svhr-1. Neutron flux was 3.00 × 107 cm-2s-1 which is 
lower than needed neutron flux. In order to study neutron penetration in human body, 
an experiment with water phantom was conducted. Neutron flux was 5.00 × 106 cm-
2s-1 at 0.0 cm depth and 3.00 × 107 cm-2s-1 at the depth of 0.8 cm and then decreased 
xxiii 
 
to 1.00 × 106 cm-2s-1 at the depth of 8.1 cm. Neutron spectrum measurement was done 
with MICROSPEC-2. The spectrum obtained was as expected. The highest spectrum 
count was around thermal neutron energy and decreasing as neutron energy increased. 
The experiment  is continued with a cadmium plate, B4C plate, lead plate, water in 
aluminium case and ice in aluminium case were placed at the front of MICROSPEC-
2. Ice had produced thermal neutron of 0.05 counts per second. Water produced 0.04 
counts per second. The conclusion of this study is that the thermal column of 
Malaysian TRIGA MARK II reactor is sufficient to be used in cancer treatment based 
on BNCT method.
 CHAPTER I 
INTRODUCTION 
 
 Cancer is one of the major causes for human death. Cancer patients are reported 
spending more than $18,000 on care (Bach et al., 2012). There are numerous studies 
conducted around the world to help in curing cancer. Some of the methods as reported by 
American Cancer Society (2015) to treat cancer are surgery, chemotherapy, targeted 
therapy, immunotherapy, hyperthermia, photodynamic therapy, laser therapy and 
radiation therapy. 
 
Surgery can be used to diagnose, treat, or even help prevent cancer in some cases. Surgery 
often offers the greatest chance for cure, especially if the cancer has not spread to other 
parts of the body. The second option is chemotherapy which is the use of medicines or 
drugs to treat cancer. The third choice is targeted therapy which is a newer type of cancer 
treatment that uses drugs or other substances to more precisely identify and attack cancer 
cells, usually while doing little damage to normal cells. Targeted therapy is a growing part 
of many cancer treatment regimens. The other approach is immunotherapy which is a 
treatment that uses body's own immune system to help fight cancer. The idea of using heat 
to treat cancer had gived mixed results (National Cancer Institute, 1992). Today, newer 
tools allow more precise delivery of heat, and hyperthermia is being studied for use against 
many types of cancer. Stem cell transplants are also used to treat cancer. Photodynamic 
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therapy (PDT) is a treatment that uses special drugs, called photosensitizing agents, along 
with light to kill cancer cells. The drugs only work after they have been activated or 
"turned on" by certain kinds of light. The lasers treatment can be used in two ways to treat 
cancer either to shrink or destroy a tumor with heat or to activate a chemical (known as a 
photosensitizing agent) that kills only the cancer cells. Though lasers can be used alone, 
they are most often used with other cancer treatments, such as chemotherapy or radiation. 
Lasers are also being studied for treating or preventing side effects of common cancer 
treatments. For instance, some studies are looking at how low-level laser therapy (LLLT) 
might be used to prevent or treat severe mouth sores caused by chemotherapy, and how 
they may be used to treat the swelling (lymphedema) that can result from breast surgery 
(National Cancer Institute, 1992). Finally, radiation therapy which uses high-energy 
particles (e.g. proton, alpha, beta and neutron) or ionising electromagnetic radiation (e.g. 
X-rays and gamma-rays) to destroy or damage cancer cells. It is one of the most common 
treatments for cancer, either by itself or along with other forms of treatment.  
 
One type of radiation therapy commonly used involves photons. X-rays were the first form 
of photon radiation to be used to treat cancer. Depending on the amount of energy they 
possess, the rays can be used to destroy cancer cells on the surface of or deeper in the 
body. The higher the energy of the X-ray beam, the deeper the X-rays can go into the 
target tissue. Gamma are another form of photons. Gamma are produced spontaneously 
as certain elements (such as radium, uranium, and cobalt) release radiation as they 
decompose, or decay. Each element decays at a specific rate and gives off energy in the 
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form of gamma and other particles. X-rays and gamma have the same effect on cancer 
cells (National Cancer Institute, 1992).  
 
Neutron therapy uses beams of neutrons to attack cancer cells. There are two advantages 
in using neutrons instead of electrons or photons. The first is that neutron beams have 
much more power. They deposit about 20 to 100 times as much energy into the target 
tissue as other radiation therapy does. The second is that neutron beams have a higher 
probability to damage both strands of a cell’s DNA, whereas regular radiation in general 
damages only one strand. This makes it harder for cells to repair neutron beam damage 
and harder for them to survive the treatment. So neutron therapy is a good choice in cases 
when tumors are resistant to other radiation (Seattle Cancer Care Alliance, 2015). 
 
An alternative cancer treatment that can treat cancer using neutron beams is called Boron 
Neutron Capture Therapy (BNCT). It is a very promising cancer treatment using the 
neutron radiation which can be obtained from either a low-flux nuclear research reactor 
or neutron generator and it is the interest of this study. BNCT exploits the selective 
deposition in tumor cells of boron carriers, boronophenylalanine (BPA) and sulfhydryl 
borane (BSH), enriched with 10B isotope, and the high thermal neutron capture cross-
section of 10B. When a high boron concentration ratio between tumor and healthy tissue 
is reached, the patient is irradiated with low energy neutrons either thermal neutron or 
epithermal neutron (Durisi, 2007). When the tumor is irradiated with thermal neutrons a 
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capture nuclear reaction is induced in 10B converting it to 11B, which decays by emission 
of an alpha particle (Faião-Flores et al., 2010). BNCT is a binary radiation therapeutic 
modality for cancer treatment. As a binary treatment modality, BNCT is based on the 
reaction between the non-radioactive isotope 10B and thermal neutrons. Neutron is a 
particle contained and formed the nucleus and is neutral because it does not have electrical 
charge. Neutrons, especially thermal neutrons can be absorbed by atomic nuclei that they 
collide with, creating a heavier isotope of the chemical element as a result. In BNCT, 10B 
will capture thermal neutron and became unstable. It will then change to 7Li isotope after 
emitting α and γ each with respectively linear energy transfer (LET). BNCT is done by 
firstly, a stable isotope of boron-10 (10B) is administered to the patient via a carrier drug 
and then the patient is irradiated with a neutron beam. 10B will then undergo the capture 
reaction 10B(n, α)7Li where 10B capture cross-section for thermal neutrons is 3840 barn 
(Valda et al., 2005). This is why thermal neutron is used in BNCT.  
 
LET is a measure of the force acting on a charged ionizing particle travelling through 
matter. The LET or restricted linear collision stopping power of charged particles in a 
medium is the quotient of dE by dl, where dl is the distance traversed by the particle and 
dE is the mean energy-loss due to collisions. LET depends on the velocity, charge and 
mass of the particle (International Commission on Radiation Units and Measurements, 
1970). A high LET of emitted charged particles in BNCT are lethal only to the cells in 
close proximity to the reaction point because their range is ~10 μm (Valda et al., 2005) 
this is the mean cell diameter. Therefore, BNCT treatment is a very much localized 
procedure which make this treatment a real advantage over others. 
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BNCT is a radiation therapy for the treatment of cancers like melanoma and glioblastoma 
multiforme. As for the two common cancers studied for BNCT, Burton et al. (2007) has 
defined melanoma as a highly malignant tumour of melanin-forming cells, the 
melanocytes. Such tumour usually occurs in the skin but are also found in the eye and the 
mucous membranes. They may contain melanin or be free of pigment. Spread of this 
cancer to other parts of the body, especially to the lymph nodes and liver, is common. The 
response rate to conventional chemotherapy is poor. 
 
Glioblastoma is described as the most aggressive type of brain tumour derived from non-
nervous (glial) tissue (Burton et al., 2007). Its rapid enlargement destroys normal brain 
cells, with a progressive loss of function, and raises intracranial pressure, causing 
headache, vomiting, and drowsiness. Treatment is never curative and the prognosis is 
poor. The evident from data compiled andsummarized by Barth et al. (2012), had shown 
that the clinical results obtained in treating patients with either primary or recurrent high 
grade gliomas, there has been significant progress in improving the clinical results. 
Specifically, increasing the dose of BPA and administering it over a longer time period or 
combining BNCT with a photon boost, as has been carried out in Japan, have resulted in 
the best survival data obtained to date using BNCT to treat patients with gliomas. 
 
Kreiner et al. (2014) had made a comparison of variety of possible charged-particle 
induced nuclear reactions and the characteristics of the resulting neutron spectra are 
discussed along with the worldwide activity in suitable accelerator development. 
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Endothermic 7Li(p,n)7Be and 9Be(p,n)9B and exothermic 9Be(d,n)10B are compared. Be 
as a target leads to stable products. This is a significant advantage for a hospital-based 
facility. 9Be(p,n)9B needs at least 4–5 MeV bombarding energy to have a sufficient yield, 
while 9Be(d,n)10B can be utilized at about 1.4 MeV, implying the smallest possible 
accelerator. This reaction operating with a thin target can produce a sufficiently soft 
spectrum to be viable for accelerator-based BNCT (AB-BNCT). The machines considered 
are electrostatic single ended or tandem accelerators or radiofrequency quadrupoles plus 
drift tube linear accelerator (Linacs). 
 
There are many studies on BNCT using research reactors. Long term goal for this research 
is to develop a cancer treatment facility which is safe and practical by using neutron 
emitted by a low flux research reactor. Firstly,  it needs to establish a suitable flux of 
neutron beams. For TRIGA types research reactors, thermal column is mainly design to 
produce thermal/epithermal neutrons which can be utilized for BNCT. It is, therefore, the 
thermal column of Malaysian TRIGA MARK II Reactor was used to produce thermal 
neutron source for this research. In order to build a BNCT facility outside the reactor, 
neutron collimator, neutron moderator and shielding for neutron and gamma-ray were 
required to ensure the safety and practicality of the procedure. 
 
Collimator is needed to collimate neutron beam from thermal column and sending them 
to the target area outside the reactor wall. Material used in collimator must not either 
absorb or slowing down the neutron. Clark et al. (2009) had defined collimator as any 
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device for producing a parallel beam of radiation. Neutron moderator is needed to reduce 
the velocity of fast and ephitermal neutrons which means reducing their energy to thermal 
energy producing more thermal neutron. Clark et al. (2009) had defined moderator as a 
substance that slows down free neutrons in a nuclear reactor, making them more likely to 
cause fissions of atoms of uranium-235 and less likely to be absorbed by atoms of 
uranium-238. Moderators are light elements, such as deuterium (in heavy water), graphite, 
and beryllium, to which neutron can impart some of their kinetic energy on collision 
without being captured. Neutrons that have had their energies reduced in this way are said 
to have been thermalized or to have become thermal neutrons. Neutron shielding is needed 
to avoid unwanted exposure of patient and radiation worker to the neutron. It is the same 
for gamma-ray. Clark et al. (2009) had defined shielding as a barrier used to surround a 
source of harmful or unwanted radiations. 
 
1.1 PROBLEM STATEMENT 
 
 BNCT treatment was studied around the world and Finland has already conducted 
treatments because the conventional treatments are not totally successful in curing cancer 
(Auterinen and Kankaanranta, 2001). Despite recent improvements in multimodal 
therapies that include surgery, radiotherapy and chemotherapy, glioblastoma (GBM) 
patients in particular continue to have a short median overall survival (OS) time of less 
than 18 months (Hopewell et al., 2010a).  
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Mallick (2014) defined OS as a term that denotes the chances of staying alive for a group 
of individuals suffering from a cancer. It denotes the percentage of individuals in the group 
who are likely to be alive after a particular duration of time. At a basic level, the overall 
survival is representative of cure rates. 5-year rates are reported for many cancers 
including high grade lymphomas because those who survive 5 years are quite likely to be 
cured of their disease. In some slow growing and low grade malignancies like follicular 
lymphoma where late relapses are common, the 10 year overall survival is more 
representative of cure rates. 
 
Dose escalation studies using conventional radiation or late stereotactic irradiation have 
been intensively investigated; however, there is no randomized study which supports the 
survival benefit of these methods at a high evidential level. The current standard care of 
GBM is maximal safe surgical resection, conventional radiation and chemotherapy using 
temozolomide, by which the life expectancy is 15 months. BNCT however had produced 
a median overall survival time of 17.6 months (Hopewell et al., 2010a). 
 
The volume of tumor with decrease diffusion analyzed by Hiramatsu et al. (2013) for two 
days was the highest indicator of patient survival time for BNCT. Most of hepatocellular 
carcinomas (HCC) are thought to be incurable by many medical practitioners, and also 
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limited surgical operation, even chemotherapy, or radiation therapies are available for a 
prolonged survival (Yanagie et al., 2010). 
 
Malaysia shares the same problems. Treatments used such as surgery, anti-cancer drugs 
and radiotherapy (Ibrahim, 2004) are not successful enough in curing cancer. The 
traditional approach has not achieved the desired results as far as oncology and 
radiotherapy is concerned (Ibrahim, 2004). There is neither simulation nor measurement 
done for neutron and gamma-ray beam outside Malaysian TRIGA MARK II Reactor’s 
thermal column. Neutron collimator and shielding are not fabricated to use outside the 
thermal column. The available beamport are underused. This situation is so unfortunate 
because Malaysian TRIGA MARK II reactor is believed to be able to supply a sufficient 
neutron beam for BNCT treatment. This study will optimize the usage of Malaysian 
TRIGA MARK II Reactor. 
 
1.2 SIGNIFICANCE OF RESEARCH 
 
 There are interesting successful results from BNCT research conducted around the 
world. Two hundred and one (201) patients whom suffered with brain tumors, where 
eighty one (81) patients suffered with glioblastoma, forty five (45) patients suffered with 
anaplastic astrocitomas, eight (8) patients suffered with brain stem gliomas, six (6) 
patients suffered with meningiomas and the rest suffered with other tumors had been 
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treated with BNCT in Japan. It was found that forty (40) patients out of two hundred and 
one (201) patients were alive at the end of three (3) years and ten (10) patients survived 
more than ten years (Hatanaka et al., 1991). 
 
Other successful results for BNCT are: firstly, an ex-glioblastomas patient, 68 years old, 
lived 18 years and is in good shape. Secondly, there is a man who was operated on for 
astrocytoma was given a course of accelerator radiation, then underwent BNCT, has 
survived 12 years and his mind is still clear (Hatanaka et al.,1991). Thirdly, a young 
woman lived normally for 9 years after her treatment for a grade III astrocytoma which 
was a huge tumor with 9 cm in diameter in the right frontal lobe. This was because she 
has no trace of surgery or radiation damage in her appearance or performance (Hatanaka 
et al., 1991).  
 
Figure 1.1 shows a few results from BNCT treatment reported by Shiroya (2005). There 
is also 1 and 2 years patient survival rates of 80.0% and 53.3%, respectively and the 3 
years patient survival rates of 26.6% was reported by Shirakawa et al. (2010).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 1.1: A few results of BNCT treatment (Shiroya, 2005). 
 
The advantage of BNCT as a high LET radiation and tumor-selective radiation without 
serious damage of surrounding normal-tissue, BNCT is effective and safe in the patients 
whom with inoperable, locally advanced head and neck cancers even if that recur at 
previously irradiated sites. As a result, eleven (11) patients showed complete remission 
and seven (7) patients showed partial remission of irradiated site. The effective rate was 
These 3 figures were presented by Seiji Shiroya (2005). 
These 3 figures were presented by Seiji Shiroya (2005). 
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90%. No severe, acute or chronic normal tissue reactions were observed in any patients 
(Aihara et al., 2010). 
 
There are many other advantages in applying BNCT to head and neck cancers. The first 
advantage is the head and neck has many important physiological and cosmetic functions. 
Therefore, organ preservation is one of the most important things. The second advantage 
is there are many patients that recur after intensive treatment including surgery and 
chemoradiotherapy, and locally advanced that cannot be controlled by conventional 
cancer therapy. The third advantage is that head and neck cancers exist superficially and 
are not very far from the skin surface (Aihara et al., 2010). The other results from clinical 
study are overall survival rates of 1 and 2 years were 53.8% and 32.3 %, respectively, and 
the disease free survival rates of 1 and 2 years were 34.2% and 0 %, respectively. 
However, the loco-regional progression-free survival rates of 1 and 2 years were 58.8% 
and 47.7%, respectively. The loco-regional progression-free survival rate of one year was 
100% and overall survival rate was 100% at 18 months (Aihara et al., 2010). Three (3) 
years and six (6) years survival rate was 40%, and 24% respectively by using Kaplan-
Meier analysis (Kato et al.,2001). 
 
Twelve (12) patients with cancer of the head and neck that had recurred at the same place 
after a surgery and conventional radiation therapy had been treated again with BNCT in 
Finland. Ten (10) patients, or 83%, had responded well to BNCT, and two (2), or 17%, 
had tumor growth stabilization for 5.5 and 7.6 months, respectively. The average duration 
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of response was 12.1 months and four (4) patients, or 33%, were alive without recurrence 
with a median follow-up of 14 months (Volkin and Dargan, 2007).  
 
In other clinical study, ten (10) patients received two treatments of BNCT, and two (2) 
patients received one treatment conducted in Finland. The results were shown that seven 
(7) of the patients, or 58%, had achieved a complete response, while three (3), or 25%, 
had experienced a partial response. A stabilized disease had been achieved for the 
remaining two (2) patients (17%) for a period of 5.5 and 7.6 months. Overall, the median 
time to disease progression was 9.8 months, while median survival was 13.5 months 
(Nelson, 2007).  
 
In a clinical study of the other cancer, the mean survival times of the patients with 
glioblastoma multiforme treated at Brookhaven, United States of America, were 15 
months in protocol group 1, and more than 10 months in groups 2 and 3; the corresponding 
times for conventional therapy are 10.5 months in group 1 and similar to those seen so far 
in the other groups (Feinendegen, 1998). Most of aged-GBM patients tend to be suffering 
from cognitive function after conventional radiotherapy therefore BNCT can contribute 
in the improvement of clinical outcome in such aged patients (Kageji et al., 2001). 
Increasing of radiation dose can achieve complete remission of GBM with BNCT 
(Nakagawa et al.,2003). 
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From light microscopy analysis conducted for BNCT, the result is BNCT had selectively 
damages tumor blood vessels, but had spare precancerous and normal tissue vessels. 
Selective tumor lethality would thus result from selective blood vessel damage rather than 
from selective uptake of the boron compound (Trivillin et al.,2006).  
 
BNCT treatment was expanded further to treat liver cancer. BPA-BNCT had induced 
significant partial remission of experimental implanted colorectal tumor nodules in the 
liver 2 and 3 weeks post irradiation. The absence of acute normal liver changes had proved 
a safe escalation of the radiation dose (Pozzi et al., 2013). The potential clinical advantage 
of BNCT towards otherforms of radiotherapy is the possibility to selectively deliver higher 
radiation doses to cancerous tissue, without damaging healthy tissue involved (Schütz et 
al., 2010). 
 
Metastatic malignant melanomas are largely refractory to existing therapies so new 
treatment strategies are urgently needed and BNCT is the best option (Rossini et al., 
2015). The human neuroblastoma cell lines (SH-SY5Y cells) are irradiated by 7Li ions 
and by means of the clone-forming method and flow cytometry; the damage effects of 
neurocytes are analyzed. The cells survival fraction in the consequence of 7Li irradiation 
reduces obviously when compared with γ-rays irradiation (Yiguo et al., 2010). 
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No acute symptoms were reported during or after irradiation of BNCT for malignant 
meningioma. No treatment related deaths occurred and no deaths have occurred in the 
follow up time of 14 months. It was concluded that BNCT is safe and effective in the 
treatment of recurred malignant meningioma patients (Kankaanranta et al., 2001).  
 
From five (5) patients treated with BNCT for cutaneous malignant melanoma, again there 
is no toxic or adverse effects. The treated cancer nodules in the skin responded well, and, 
depending on size, were seen to fully disappear with no recurrence in one (1) patient 2.5 
years after BNCT. The normal skin showed lower radiation effects than are normally seen 
after conventional radiotherapy. The convenience of a single BNCT treatment, versus 
multiple treatments over about two months required by current conventional radiotherapy, 
considered to improve the quality of life (Feinendegen, 1998).  
 
The geometrical factors, g, from the BNCT plans, which describes target volumes 
receiving doses under the prescribed doses and normal brain volume covered by the 
prescribed doses, were lowest compared to those for the other modalities. For the BNCT 
plans, maximum dose escalation up to 2.08 times the prescribed dose was possible without 
exceeding normal brain tolerance dose (Jung et al., 2010). 
 
From the measurements and with MONTE CARLO verification for neutron flux at the 
thermal column of Malaysian TRIGA MARK II reactor done by Munem (2007), it was 
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clear that there is sufficient neutron flux for BNCT treatment in Malaysian TRIGA MARK 
II reactor at Nuclear Malaysia. The quality of the neutron flux is as good as is required for 
standard BNCT treatment. The next step is to direct these neutrons outside the reactor to 
be used in BNCT treatment with full safety precautions. The availability of the neutron 
flux and the support from Malaysian Nuclear Agency had given the opportunity for this 
research to be done. This research will produce neutron and gamma beam data from 
MCNP code simulation together with experimental data. Neutron beam research set-up 
outside thermal column will be developed to include a good neutron collimator and a safe 
neutron and gamma shielding. 
 
The other reasons for the interest in BNCT studies in Malaysia are (Shukri, 2005): 
i. The result for development of new compounds that can accumulate into 
tumours with a ratio of greater than three (3). 
ii. The newer method for measuring boron concentration in tissues and in 
tumours. 
iii. The availability of computer based dose calculation algorithm which allow 
accurate determination of dose in boron-containing tissues. 
iv. BNCT also does not produce a mental retardation as occurred in 
conventional radiotherapy. 
 
1.3 OBJECTIVES OF RESEARCH 
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1. To simulate a BNCT treatment for Malaysian Training, Research, Isotope 
Production, General Atomic MARK II (TRIGA MARK II) reactor and then 
calculate the fluxes of neutron and gamma-ray. 
 
2. To establish a neutron beam collimator as well as neutron and gamma-ray 
shielding set-up where the neutron collimator and neutron and gamma-ray 
shielding will be test together with neutron moderator. 
 
3. To compare between the results from TLD, Fission Chamber and NP-100 
detectors with simulation results. 
 
1.4 SCOPE OF RESEARCH  
 
 This study will be confined to investigate the availability, suitability and quality 
of thermal neutron beam exiting from thermal column of Malaysian TRIGA MARK II 
reactor. This thermal neutron beam is prepared to be used in BNCT treatment. Collimator 
and shielding were fabricated to be used in neutron and gamma-ray measurement. For fast 
and epithermal neutron shielding, a polyethylene and water were used. For gamma-ray 
shielding, lead was used. The collimator is made from polyethylene pipe with 8 cm of 
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diameter filled with paraffin. Thermal neutron flux were measured with TLD, Fission 
Chamber and NP-100 detectors. Data obtained were compared with simulation results 
from MCNP code that was done earlier.  
 
There are a lot of constraints and obstacles in this study. Time constraints had prevent the 
repetation of measurements conducted. Budget constraints had highly limited the use of 
materials and instruments. Best materials and equipments are unaffordable. Available 
materials and instruments in Universiti Sains Malaysia and Malaysian Nuclear Agency 
were mostly used throughout this study. Safety issue had limited research activities and 
studies that can be done. This study must not change the structure of the reactor because 
it will affect other reactor usage. At this stage of study, all the collimator, moderator and 
shielding were fabricated as a portable equipments as not to disturb the other operations 
of the reactor.  
 
1.5 STRUCTURE OF THESIS  
 
 The work summarizes in this thesis describes the characterization of neutron beam 
exiting from thermal column of Malaysian TRIGA MARK II reactor. Generally, the 
content of this thesis is organized as follows: 
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Chapter 1 highlights a general introduction on the BNCT treatments and the importance 
of BNCT treatment in Malaysia and around the world. In addition, the problem statement 
and objectives of this thesis are listed out. 
 
Chapter 2 contains the theoretical background of BNCT treatment. The quality of neutron 
beam needed is presented with the examples from other studies around the world. The 
process and procedure in BNCT treatments are discussed with the list of all facilities 
needed and most importantly the safety precautions. Literature review is also included in 
this Chapter. 
 
Chapter 3 discusses the materials and methodology of this work. In this Chapter, all 
materials used in fabrication of collimator, shielding and moderator and in experiment 
done are discussed in detail. Methodology used in simulation, fabrication and neutron and 
gamma-ray measurements are also discussed. 
 
In Chapter 4, the results and discussions of simulation and calculation of neutron and 
gamma flux are presented. This Chapter also discusses the results of neutron and gamma 
measurements done with fabricated collimator and shielding. The discussion is extended 
further with the result of moderators investigated in this research. Finally, in Chapter 5, 
the conclusions of this thesis and recommendations for future works are presented. 
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CHAPTER II 
 
THEORY AND LITERATURE REVIEW 
 
2.1 THEORY OF BNCT 
 
 BNCT is a binary radiation therapeutic modality for cancer treatment. As a binary 
treatment modality, BNCT is based on the reaction between the non-radioactive isotope 
10B and thermal neutrons. The thermal neutron absorption cross-section for 10B is 3837 
barn and with 94% probability, the capture reaction 10B(n, α)7Li yields 1.47 MeV of 
kinetic energy for 4He and 0.84 MeV of kinetic energy for 7Li. The range of energy release 
is 9 and 5 µm, respectively, which is around one cell diameter for about 10 µm (Liu et al., 
2001). 
 
2.1.1 Neutron and Its Properties 
 
In the interaction between neutrons and nuclei, the kinetic energy of the neutron 
determines the nature of the interaction. A characteristic quantity is the reduced de Broglie 
wave length ƛ = λ/2π of the neutron-nucleus center-of-mass system, defined by 
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ƛ = √ ħ
2
2𝑀𝐸
         2.1 
where M is the reduced mass, E the kinetic energy in the center of mass frame, and 
ħ = h/2π is the reduced Planck constant. If the nucleus has a mass A times that of the 
neutron mn, then 
 𝑀 =
𝐴
𝐴+1
× 𝑚𝑛        2.2 
at very low neutron energies, typcially in the meV range and below, this wavelength 
has a size of the order of the spacing between the nuclei in their material, for 
example, a crystalline structure (Cacuci, 2010).  
Fully thermalized neutrons behave like an ideal gas and can, therefore, be described in 
good approximation by Maxwell–Boltzmann statistics. The neutron density, that is, the 
number of neutrons per unit of volume, has a Maxwell–Boltzmann velocity distribution 
nv(v) of the form 
 nv(v) = 4π (
𝑚
2𝜋𝑘𝑇
)3/2 𝑣2𝑒𝑥𝑝 (−
𝑚𝑣2
2𝑘𝑇
)      2.3 
where k is the Boltzmann constant, m the neutron mass, and T the temperature. 
This distribution shows a maximum at 𝑣 = √2kT/m  corresponding to a kinetic 
energy of Emax = kT. For a velocity of 2200 ms
-1, used as a reference for thermal 
neutrons, this gives Emax = 25.3 meV, λ = 0.18 nm, and T = mv2/2k = 293.6 K, 
which is practically room temperature (Cacuci, 2010).  
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From the velocity distribution nv(v) one can obtain the distribution nE(E) of the kinetic 
energy E, the distribution nt(t) of the time-of-flight t, and the distribution nλ(λ) of the 
wavelength λ using the relation 
 nv(v)dv = nE(E)dE = nt(t)dt = nλ(λ)dλ      2.4 
where dv, dE, dt, and dλ are obtained from taking the derivates of the 
expressions 
 𝐸 =
1
2
𝑚𝑣2 =
1
2
𝑚
𝐿2
𝑡2
        2.5 
and 
 λ = h/mv = ht/mL        2.6 
 where L is the length or distance. 
Accurate knowledge of the thermal neutron capture and fission cross sections are of 
paramount importance for many applications and considerable experimental as well as 
evaluation effort was expended in obtaining precise and consistent constants at a neutron 
energy of 0.0253 eV (velocity v = 2200 ms-1) (Cacuci, 2010). 
 
Neutron interaction with matter can be divided into two classifications which are 
absorption and diffraction. In diffraction interaction, neutron is still free after collision 
even though its energy is decreased. In absorption interaction, neutron is captured by a 
nucleus and secondary particle will be produced. Thermal cross section is equal to the sum 
of the scattering cross section and the absorption cross section. The absorption cross 
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section typically varies as 1/v where v is the velocity of the neutron. The scattering cross 
section can be more complex as solid state effects take place. Neutrons can undergo Bragg 
scattering by any crystalline material present, undergo paramagnetic scattering with the 
target nuclei and neutrons can be up-scattered or down-scattered in energy from the 
thermal motion of the nuclei they interact with. 
 
2.1.1.1 Absorption 
 
Neutron absorption of a nucleus will make the nucleus to be excited then emit 
particles and radiations return to its initial state. Thermal neutron can experience four 
types of absorption interaction with a nucleus of an atom which are 
i. (n,γ) reaction: Nucleus of an atom will capture neutron and became excited 
with excessive energy. The nucleus will then emit gamma and therefore 
will be back to stable state. 
ii. (n,α) reaction. 
iii. (n,p) reaction. 
iv. Fission: Nucleus of an atom can absorb neutron and became unstable. The 
nucleus then splitted into two parts. Substances that can produce fission are 
233U, 235U and 239Pu. 
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The probability of neutron reaction with a nucleus is determined by neutron reaction cross-
section. Consider one mono-energy neutron source that is moving toward a nucleus. The 
number of neutron per unit time per unit area that moving toward the nucleus is called 
neutron flux (φ) and given by an equation (Wagiran, 1997), 
 
 φ = nv         2.7 
where n is the number of neutron per unit volume and v is neutron velocity. 
When the target material contain N atom per unit volume for a width of dx, the 
number of nucleus per unit area is N·dx.  
 
If C is neutron absorption per unit area, neutron cross-section is given by the equation 
(Wagiran, 1997), 
 
 σ = 
𝐶
𝜑𝑁𝑑𝑥
         2.8 
 
For a system with neutrons of multiple energy where n(E) is neutron intensity in energy 
range of dE, the number of neutron in energy range from E to (E + dE) is N(E)dE. The 
total neutron flux from all those energy where v(E) is their velocity at energy E is 
(Wagiran, 1997), 
